GL1X · GenesisL1 explorer

MolNFT v1 · #136950 · protein

Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain

5V8U · Botulinum neurotoxin type a: “Small molecule inhibitor abs-143 bound to the botulinum neurotoxin serotype a light chain”. X-ray diffraction, 2 ligands (90M, ZN), 9 pockets (best druggability 0.77). MolNFT v1 #136950 on GenesisL1: 3D…

PDB
5V8U
Type
protein
Length
774 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Botulinum neurotoxin type a
EC
3.4.24.69
UniProt
P10845
Ligands
90M, ZN
Pockets
9 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABotulinum neurotoxin type a (EC 3.4.24.69)protein38933% helix, 19% strandP10845
BBotulinum neurotoxin type a (EC 3.4.24.69)protein38532% helix, 18% strandP10845

Ligands and binding sites

  • 90M · N-[3-(4-fluorophenyl)-4-methyl-1H-pyrazol-5-yl]-2-sulfanylacetamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17930.770.8056empty
23510.610.7846ZN, 90M
32180.590.803390M
42640.580.7844empty
52000.580.8129empty

Interfaces

1 interface between chains.

  • A–B · 1837 Ų buried · 22 hydrogen bonds · protein-protein

Compared structures

  • 5V8U · Small Molecule Inhibitor ABS-143 Bound to the Botulinum Neurotoxin Serotype A Light Chain · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.